Skip to main content
Erschienen in: Digestive Diseases and Sciences 5/2014

01.05.2014 | Original Article

A Diagnostic Approach to Patients with Suspected Lactose Malabsorption

verfasst von: Tsachi Tsadok Perets, Einav Shporn, Shoshana Aizic, Elena Kelner, Sigal Levy, Yifat Bareli, Lea Pakanaev, Yaron Niv, Ram Dickman

Erschienen in: Digestive Diseases and Sciences | Ausgabe 5/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The lactose breath test (LBT) is the standard technique for diagnosis of lactose malabsorption. However, it is time-consuming, strenuous for the patient and has been reported to have low sensitivity. The lactose intolerance quick test (LIQT) measures lactase activity in duodenal biopsies and may be performed as part of upper gastrointestinal endoscopy.

Aim

The purpose of this study was to assess the role of the LBT and LIQT in the case management of suspected lactose malabsorption.

Methods

The study group included 69 consecutive patients evaluated by the LBT followed by the LIQT. The test results were compared, and the sensitivity, specificity, and predictive values of the LBT were calculated.

Results

Mean age of the patients was 54.4 years, male/female ratio was 1:3, and mean body mass index was 25.2. None had celiac disease on duodenal biopsy. The LIQT was positive for hypolactasia in 55 patients (80 %): mild in 14 (25 %) and severe in 41 (75 %); 10 (18 %) were symptomatic during the LBT. The LBT was positive for lactose malabsorption in 32 patients (46 %). Of the 37 patients with normal findings on the LBT, 24 (65 %) had positive findings on the LIQT: 11 (30 %) mild hypolactasia, 13 (35 %) severe hypolactasia. In one case, the LBT was positive and the LIQT was negative. The LBT had a sensitivity of 56 %, specificity 93 %, positive predictive value 97 %, and negative predictive value 35 %.

Conclusions

The LBT may serve as a diagnostic screening tool for lactose malabsorption. Symptomatic patients with negative LBT results should be referred for second-line testing with the LIQT.
Literatur
1.
Zurück zum Zitat Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr. 1988;48:1079–1159.PubMed Scrimshaw NS, Murray EB. The acceptability of milk and milk products in populations with a high prevalence of lactose intolerance. Am J Clin Nutr. 1988;48:1079–1159.PubMed
2.
Zurück zum Zitat Swagerty DL Jr, Walling AD, Klein RM. Lactose intolerance. Am Fam Physician. 2002;65:1845–1850.PubMed Swagerty DL Jr, Walling AD, Klein RM. Lactose intolerance. Am Fam Physician. 2002;65:1845–1850.PubMed
3.
4.
Zurück zum Zitat Qiao R, Huang C, Du H, Zeng G, Li L, Ye S. Milk consumption and lactose intolerance in adults. Biomed Environ Sci. 2011;24:512–517.PubMed Qiao R, Huang C, Du H, Zeng G, Li L, Ye S. Milk consumption and lactose intolerance in adults. Biomed Environ Sci. 2011;24:512–517.PubMed
5.
Zurück zum Zitat Vuorisalo T, Arjamaa O, Vasemägi A, Taavitsainen JP, Tourunen A, Saloniemi I. High lactose tolerance in North Europeans: a result of migration, not in situ milk consumption. Perspect Biol Med. 2012;55:163–174.PubMedCrossRef Vuorisalo T, Arjamaa O, Vasemägi A, Taavitsainen JP, Tourunen A, Saloniemi I. High lactose tolerance in North Europeans: a result of migration, not in situ milk consumption. Perspect Biol Med. 2012;55:163–174.PubMedCrossRef
6.
Zurück zum Zitat Casellas F, Aparici A, Casaus M, Rodríguez P, Malagelada JR. Subjective perception of lactose intolerance does not always indicate lactose malabsorption. Clin Gastroenterol Hepatol. 2010;8:581–586.PubMedCrossRef Casellas F, Aparici A, Casaus M, Rodríguez P, Malagelada JR. Subjective perception of lactose intolerance does not always indicate lactose malabsorption. Clin Gastroenterol Hepatol. 2010;8:581–586.PubMedCrossRef
7.
Zurück zum Zitat Bolin T. IBS or intolerance? Aust Fam Physician. 2009;38:962–965.PubMed Bolin T. IBS or intolerance? Aust Fam Physician. 2009;38:962–965.PubMed
8.
Zurück zum Zitat Zhao J, Fox M, Cong Y, et al. Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2010;31:892–900.PubMed Zhao J, Fox M, Cong Y, et al. Lactose intolerance in patients with chronic functional diarrhoea: the role of small intestinal bacterial overgrowth. Aliment Pharmacol Ther. 2010;31:892–900.PubMed
9.
Zurück zum Zitat Corlew-Roath M, Di Palma JA. Clinical impact of identifying lactose maldigestion or fructose malabsorption in irritable bowel syndrome or other conditions. South Med J. 2009;102:1010–1012.PubMedCrossRef Corlew-Roath M, Di Palma JA. Clinical impact of identifying lactose maldigestion or fructose malabsorption in irritable bowel syndrome or other conditions. South Med J. 2009;102:1010–1012.PubMedCrossRef
10.
Zurück zum Zitat Bate JP, Irving PM, Barrett JS, Gibson PR. Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol. 2010;22:318–326.PubMedCrossRef Bate JP, Irving PM, Barrett JS, Gibson PR. Benefits of breath hydrogen testing after lactulose administration in analysing carbohydrate malabsorption. Eur J Gastroenterol Hepatol. 2010;22:318–326.PubMedCrossRef
11.
Zurück zum Zitat Montalto M, Curigliano V, Santoro L, et al. Management and treatment of lactose malabsorption. World J Gastroenterol. 2006;12:87–91. Montalto M, Curigliano V, Santoro L, et al. Management and treatment of lactose malabsorption. World J Gastroenterol. 2006;12:87–91.
12.
Zurück zum Zitat Rasinpera H, Savilahti E, Enattah NS, et al. A genetic test which can be used to diagnose adult-type hypolactasia in children. Gut. 2004;53:1571–1576.PubMedCentralPubMedCrossRef Rasinpera H, Savilahti E, Enattah NS, et al. A genetic test which can be used to diagnose adult-type hypolactasia in children. Gut. 2004;53:1571–1576.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Haberkorn BC, Ermens AA, Koeken A, Cobbaert CM, van Guldener C. Improving diagnosis of adult-type hypolactasia in patients with abdominal complaints. Clin Chem Lab Med. 2011;50:119–123.PubMed Haberkorn BC, Ermens AA, Koeken A, Cobbaert CM, van Guldener C. Improving diagnosis of adult-type hypolactasia in patients with abdominal complaints. Clin Chem Lab Med. 2011;50:119–123.PubMed
14.
Zurück zum Zitat Enattah NS, Sahi T, Savilahti E, et al. Identification of a variant associated with adult-type hypolactasia. Nat Genet. 2002;30:233–237.PubMedCrossRef Enattah NS, Sahi T, Savilahti E, et al. Identification of a variant associated with adult-type hypolactasia. Nat Genet. 2002;30:233–237.PubMedCrossRef
15.
Zurück zum Zitat Kuokkanen M, Enattah N, Oksanen A, et al. Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia. Gut. 2003;52:647–652.PubMedCentralPubMedCrossRef Kuokkanen M, Enattah N, Oksanen A, et al. Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia. Gut. 2003;52:647–652.PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Koetse HA, Stellaard F, Bijleveld CM, et al. Non-invasive detection of low-intestinal lactase activity in children by use of a combined 13CO2/H2 breath test. Scand J Gastroenterol. 1999;34:35–40.PubMed Koetse HA, Stellaard F, Bijleveld CM, et al. Non-invasive detection of low-intestinal lactase activity in children by use of a combined 13CO2/H2 breath test. Scand J Gastroenterol. 1999;34:35–40.PubMed
17.
Zurück zum Zitat Hassan NA, Al-Ani MR, Lafta AM, Kassir ZA. Value of breath hydrogen test in detection of hypolactasia in patients with chronic diarrhoea. J Chromatogr. 1990;530:102–107.PubMedCrossRef Hassan NA, Al-Ani MR, Lafta AM, Kassir ZA. Value of breath hydrogen test in detection of hypolactasia in patients with chronic diarrhoea. J Chromatogr. 1990;530:102–107.PubMedCrossRef
18.
Zurück zum Zitat Arola H. Diagnosis of hypolactasia and lactose malabsorption. Scand J Gastroenterol. 1994;202:26–35.CrossRef Arola H. Diagnosis of hypolactasia and lactose malabsorption. Scand J Gastroenterol. 1994;202:26–35.CrossRef
19.
Zurück zum Zitat Kuokkanen M, Myllyniemi M, Vauhkonen M, et al. A biopsy-based quick test in the diagnosis of duodenal hypolactasia in upper gastrointestinal endoscopy. Endoscopy. 2006;38:708–712.PubMedCrossRef Kuokkanen M, Myllyniemi M, Vauhkonen M, et al. A biopsy-based quick test in the diagnosis of duodenal hypolactasia in upper gastrointestinal endoscopy. Endoscopy. 2006;38:708–712.PubMedCrossRef
20.
Zurück zum Zitat Ojetti V, La Mura R, Zocco MA, et al. Quick test: a new test for the diagnosis of duodenal hypolactasia. Dig Dis Sci. 2008;53:1589–1592.PubMedCrossRef Ojetti V, La Mura R, Zocco MA, et al. Quick test: a new test for the diagnosis of duodenal hypolactasia. Dig Dis Sci. 2008;53:1589–1592.PubMedCrossRef
21.
Zurück zum Zitat Rao P, Rao N, Jordinson M, et al. Comparison of quick point-of-care test for small-bowel hypolactasia with biochemical lactase assay in children. J Pediatr Gastroenterol Nutr. 2012;54:401–403.PubMedCrossRef Rao P, Rao N, Jordinson M, et al. Comparison of quick point-of-care test for small-bowel hypolactasia with biochemical lactase assay in children. J Pediatr Gastroenterol Nutr. 2012;54:401–403.PubMedCrossRef
22.
Zurück zum Zitat Suchy FJ, Brannon PM, Carpenter TO. NIH consensus development conference statement: lactose intolerance and health. NIH Consens State Sci Statements. 2010;27:1–27.PubMed Suchy FJ, Brannon PM, Carpenter TO. NIH consensus development conference statement: lactose intolerance and health. NIH Consens State Sci Statements. 2010;27:1–27.PubMed
Metadaten
Titel
A Diagnostic Approach to Patients with Suspected Lactose Malabsorption
verfasst von
Tsachi Tsadok Perets
Einav Shporn
Shoshana Aizic
Elena Kelner
Sigal Levy
Yifat Bareli
Lea Pakanaev
Yaron Niv
Ram Dickman
Publikationsdatum
01.05.2014
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 5/2014
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2980-7

Weitere Artikel der Ausgabe 5/2014

Digestive Diseases and Sciences 5/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

NSCLC: Progressionsfreies Überleben unter Osimertinib fast versiebenfacht

06.06.2024 ASCO 2024 Kongressbericht

Erste Ergebnisse der Phase-III-Studie LAURA etablieren Osimertinib als neuen Therapiestandard für Menschen mit nicht-resezierbarem, EGFR-mutiertem, nicht-kleinzelligem Lungenkarzinom im Stadium III, die nach definitiver Radiochemotherapie progressionsfrei sind. Auf der ASCO-Tagung wurden diese beeindruckenden Ergebnisse besprochen.

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gute molekulare Response, aber seltener ernste Nebenwirkungen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.